Anti-SIRP[alpha] antibodies

The present invention relates to anti-SIRP[alpha] antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

Saved in:
Bibliographic Details
Main Authors VOETS, ERIK, HULSIK, DAVID LUTJE, VAN ELSAS, ANDREA, VINK, PAUL, VAN EENENNAAM, HANS
Format Patent
LanguageChinese
English
Published 01.12.2018
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to anti-SIRP[alpha] antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Bibliography:Application Number: TW20187112801